LBCL

Leah SherwoodTransplantation & Cellular Therapy | November 22, 2022
The largest study yet comparing chimeric antigen receptor (CAR) T-cell therapy with the previous standard of care (SOC)...
Leah SherwoodPrint | November 22, 2022
In second-line therapy for relapsed/refractory LBCL, which patients would you consider eligible for CAR T-cell therapy...
Cecilia BrownAggressive B-Cell Lymphoma | November 22, 2022
Axicabtagene ciloleucel, an autologous anti-CD19 CAR T-cell treatment, improved quality of life compared to standard of care ...
Advertisement
Leah SherwoodTransplantation & Cellular Therapy | November 22, 2022
Axicabtagene ciloleucel is the most cost-effective chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed ...
Leah SherwoodTransplantation & Cellular Therapy | November 14, 2022
Results from the global, phase III TRANSFORM study support liso-cel as a new second-line treatment recommendation in patients ...
Leah SherwoodTransplantation & Cellular Therapy | November 14, 2022
The overall efficacy of tisagenlecleucel was similar between the two groups. Flu/Cy led to more profound lymphocytopenia ...
Advertisement
Leah SherwoodAggressive B-Cell Lymphoma | November 14, 2022
In the study, 11 patients with relapsed/refractory diffuse LBCL were infused with anbal-cel.
Leah SherwoodAggressive B-Cell Lymphoma | November 14, 2022
Epcoritamab is a subcutaneous CD3/CD20 bispecific antibody that induces anti-tumor activity across B-cell NHL subtypes.
Kerri FitzgeraldAggressive B-Cell Lymphoma | November 14, 2022
The FDA previously approved this treatment for adults with R/R LBCL or FL who received two or more lines of systemic therapy.
Kerri FitzgeraldAggressive B-Cell Lymphoma | November 14, 2022
The primary analysis of the study was published in Nature Medicine by Sattva S. Neelapu, MD.
Leah LawrenceAggressive B-Cell Lymphoma | November 14, 2022
According to data from the ZUMA-7 trial, the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel) ...
Advertisement
Advertisement